APA (7th ed.) Citation

2-s2.0-85105366607. (2021). Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia. Case Reports in Medicine, 2021, . https://doi.org/10.1155/2021/5544848

Chicago Style (17th ed.) Citation

2-s2.0-85105366607. "Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia." Case Reports in Medicine 2021 (2021). https://doi.org/10.1155/2021/5544848.

MLA (8th ed.) Citation

2-s2.0-85105366607. "Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia." Case Reports in Medicine, vol. 2021, 2021, https://doi.org/10.1155/2021/5544848.